載入...

Intravitreal Ranibizumab for Diabetic Macular Edema with Prompt vs Deferred Laser Treatment: 3-year Randomized Trial Results

OBJECTIVE: To report 3-year follow-up within a previously reported randomized trial evaluating prompt versus deferred (for ≥24 weeks) focal/grid laser treatment in eyes treated with intravitreal 0.5-mg ranibizumab for diabetic macular edema (DME). DESIGN: Multicenter randomized clinical trial. PARTI...

全面介紹

Na minha lista:
書目詳細資料
格式: Artigo
語言:Inglês
出版: 2012
主題:
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC3490003/
https://ncbi.nlm.nih.gov/pubmed/22999634
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ophtha.2012.08.022
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!